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ABSTRACT 
 
This study aims to determine the comparison of diagnostic kit test results of the Nonstructural-1 dengue antigen which is 
currently being developed with Nonstructural-1 dengue antigen commercial kit used in hospitals using methods 
Immunocromatography of patient’s serum withDHF suspect. The study design used a cross-sectional method with a 
total one hundred and three samples that met the inclusion criteria. Collection and examination of samples were carried 
out at the Pathology Laboratory of the Education Hospital of Hasanuddin University Makassar during March to June 
2018. The results showed that the examination using the development NS1 kit obtained positive results as many as 56 
samples and negative results as many as 47 samples, while the examination using a commercial NS1 kit obtained 
positive results as many as 51 samples and negative results as many as 52 samples. The Cohen's Kappa test results 
obtained a value of p=0,000 (<0.05) indicating that there was a significant match between the development NS1 kit and 
the commercial NS1 kit used in the hospital and had a very good degree of suitability because of the Cohen's Kappa 
value obtained in the research is equal to K=0.903 (>0.75). In this study, the sensitivity level of NS1 kit development 
was 100%, specificity was 90.4%, positive predictive value was 91.1%, negative predictive value was 100%, and the 
accuracy value was 95.1%. 
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BACKGROUND 
Dengue infection is currently one of 
the major health problems in the world 
(WHO, 2011). The World Health 
Organization (WHO) estimates that around 
50-100 million cases of dengue virus 
infection occur with 24,000 deaths each 
year (Soedarto,2012). Data from all over 
the world shows that Asia ranks first in the 
number of people with Dengue 
Hemorrhagic Fever (DHF). Meanwhile, from 
1968 to 2009, WHO noted that Indonesia 
was the country with the highest DHF cases 
in Southeast Asia (Center for 
Epidemiological Data & Surveillance of the 
Indonesian Ministry of Health, 2010). 
This disease is caused by infection 
with dengue virus which is transmitted 
through the Aedes aegypti and Aedes 
albopictus mosquitoes which are infected 
with the virus and are widespread in the 
tropics and subtropics (RI Ministry of 
Health, 2011). Dengue infection can cause 
clinical manifestations that range from 
relatively mild symptoms of dengue fever to 
hemorrhagic symptoms in the form of 
Dengue Shock Syndrome (SSD) that can 
cause death, so a fast, precise and 
accurate diagnosis is needed to 
immediately treat the patient so that he 
does not fall into more weight (Young et al., 
2000). 
Early diagnosis is needed for patient 
management and monitoring of mortality 
and morbidity rates (Ramirez et al., 2009). 
The diagnosis of dengue is difficult to 
enforce on the first few days of illness 
because the symptoms that appear are not 
specific and difficult to distinguish from 
other infectious diseases so that it can 
cause a delay in diagnosis. Diagnosis of 
dengue disease in addition to assessing 
clinical symptoms also requires laboratory 
testing to confirm the diagnosis (Muhamad, 
2017). Laboratory diagnosis of dengue 
infection can be established by detecting 
specific viruses, genome sequences, 
antibodies and viral antigens (Pei-Yun & 
Jyh-Hsiung, 2004). Currently, two DHF 
diagnosis approaches are being developed, 
namely the use of anti-dengue virus 
antibodies as antigen capture or by finding 
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the viral antigen that causes dengue 
infection in serum or plasma of DHF 
patients. Both have advantages and 
disadvantages that affect the time and 
accuracy of the diagnosis (Harly & 
Basundari, 2009). 
Some serological tests of DHF have 
low sensitivity due to one of them due to the 
inefficiency of antigens used in detecting 
antibodies. Dengue virus consists of single-
stranded positive-sense RNA (ssRNA 
sense +). Inside the genome there is a 
single Open Reading Frame (ORF) that 
encodes 2 kinds of proteins, namely 
structural proteins, and non-structural 
proteins. Structural proteins consist of C 
(coreprotein/capsid/core), M (membrane 
protein, including preMembran/prM) and E 
(envelope protein) and 7 types of non-
structural proteins namely NS1, NS2A, 
NS2B, NS3, NS4A, NS4B, NS5. In 
stimulating the formation of antibodies 
among the structural proteins the highest 
immunogenicity sequence is protein E and 
followed by prM and C, while the non-
structural proteins that are most important 
are NS1 proteins. The NS1 protein is a 
glycoprotein with a molecular weight of 46-
50 kDa, this protein is excreted by cells 
infected with dengue virus and has an 
important role in the diagnosis and severity 
of the patient. (Alcon et al., 2002). 
Dengue NS1 antigen is an abundant 
non-structural glycoprotein produced by the 
virus during the early stages of infection 
and found in infected cells in the cell 
membrane and secreted into the 
extracellular space, which plays an 
important role in viral replication and 
maturation (Ni Luh, 2011). Dengue NS1 
antigen can be detected in patients with 
dengue virus serotypes 1,2,3 and 4 and can 
be detected on days 1 to 9 onset of fever. 
Protein NS1 Dengue virus is the only non-
structural protein found in dissolved form 
released and circulating in the bloodstream. 
The protein has the potential as a basis for 
developing diagnostic tools, because 
dengue NS1 antigens have high 
immunogenicity and are able to induce 
antibodies through binding activities of the 
complement system and are in high 
concentration during the initial clinical 
phase in the serum of patients who have 
primary or secondary infections (Alcon et 
al., 2002). 
Diagnosis using anti-dengue virus 
antibodies that have been developed to 
date include hemaglutination inhibition (HI), 
neutralization, immune fluorescent antibody 
test, immunosorbent assay (ELISA) 
enzyme link, complement fixation, dot 
blotting, and western blotting but the test 
still has limited time and costs (Yondri, 
2013). Other laboratory tests that can be 
done to support the enforcement of 
diagnoses of dengue virus infection are 
viral culture and isolation, Reverse 
Transcription Polymerase Chain Reaction 
(RT-PCR), serological tests (examination of 
anti-dengue IgM and IgG) and routine 
hematological examinations. Virus isolation 
and PCR are still the gold standards for 
detecting dengue virus, but there are 
limitations to these checks, especially the 
cost, time and processing techniques. 
Serological examination of anti-dengue IgM 
and IgG which is routinely and relatively 
easy to do, but still has limitations, namely 
the inability to detect the infection process 
earlier (Ni Luh, 2011). At present, a new 
examination has been developed, namely 
the development of a diagnosis of DHF with 
a detection approach to Non Structural-1 
antigens that can detect or diagnose 
dengue virus infection earlier, even on the 
first day of fever onset, because Non 
Structural-1 proteins circulate in high 
concentrations within blood of the patient 
during the initial acute phase, both during 
primary and secondary infections without 
the need to wait for antibodies to form 
(Alcon et al.,2002). The presence of the 
NS1 antigen examination is very important 
because supportive therapy and patient 
monitoring can be done immediately and 
can reduce the risk of complications and 
death. 
 In line with the background above, 
there are now many dengue Non Structural-
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1 Antigen diagnostic tools in circulation and 
have varying levels of specificity and 
sensitivity. Currently the reagent kits 
circulating in Indonesia are imported import 
reagents in the manufacture using 
recombinant antigens originating from 
strains outside Indonesia. The use of 
imported reagent kits in Indonesia with 
antigens that do not match local strains can 
cause a lack of sensitivity and specificity of 
diagnostic test kits. In addition, commercial 
reagents have a relatively expensive sale 
value. Various studies have been 
conducted to test the accuracy of the 
dengue NonStructural-1 commercial 
antigen diagnostic kits that are used in 
various health service locations and have 
examination results with varying degrees of 
accuracy. The purpose of this study was to 
determine the suitability of the results of the 
dengue Non Structural-1 antigen diagnostic 
kit test that is currently being developed 
with a commercial Non Structural-1 antigen 
kit used in hospitals by using 
immunochromatographic methods from the 
serum of patients suspected of DHF. 
 
MATERIALS AND METHODS 
Types and Design of Research 
This study was an observational 
analytic study with a cross-sectional design 
(cross-section). The research subjects were 
suspected DHF patients who underwent 
outpatient and inpatient care at the 
Hasanuddin University Higher Education 
Hospital (UH RSPTN) Makassar and 
conducted NS1 examinations. 
 
Research Place and Research Time 
Collection of suspected DHF serum 
samples and examinations will be carried 
out at the Clinical Pathology Laboratory of 
UH Makassar RSPTN during March to June 
2018. 
 
Population and Sample Techniques 
The population in this study was 
suspected DHF patients who underwent 
outpatient and inpatient care at UH 
Makassar Hospital. The sample in this 
study were all affordable populations that 
met the research criteria. The sample 
collection in this study used a purposive 
sampling method. 
 
Research Tools and Materials 
Equipment: The tools used in this 
study include: phlebotomy device in the 
form of Holder, Tourniquet, 70% alcohol 
cotton, Plastering, Flashback or Wing 
needle, 3 mL red lid plant tube, 3 mL 
K2EDTA tube, Micropipette, and Yellow tip. 
Materials used: Serum, plasma EDTA or 
Whole Blood, Panbio Dengue Early Rapid 
kit (commercial reagent) and Non 
Structural-1 dengue Antigen kit that is being 
developed is in vitro diagnostic kit dengue 
Non Structural-1 Antigen  with 
immunochromatographic testing methods 
using local strains from Indonesian isolates 
currently under development by 
Hasanuddin University Medical Research 
Center (HUMRC) in collaboration with the 
Mochtar Riady Institute for Nanotechnology 
(MRIN) to qualitatively detect Non 
Structural-1 Antigen dengue virus in human 
serum or plasma for early diagnosis of 
acute dengue infection (Yaumil, 2014). 
 
Ways of working 
 The blood of patients with 
suspected DHF taken as much as 3 ml 
through the medianacubiti or cephalica vein 
was allowed to freezer ± 30 minutes, then 
centrifugation for 15 minutes at 3600 rpm. 
Plasma serum or EDTA obtained was used 
as a sample in the study to carry out a Non 
Structural-1  dengue antigen examination. 
 Remove the dengue strip from the 
wrapper and place it on a dry flat surface 
using a disposable pipette in the diagnostic 
kit, add 3 drops (about 100 µL) of the 
sample into the sample well, turn on the 
timer (timer set for 15-20 minutes), kit 
begins to detect, it will appear purple 
moving past the reading area of the results 
in the middle part of the diagnostic kit, the 
interpretation of the results of the inspection 
is read at 15-20 minutes, after the timer has 
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reached 15-20 minutes, the results can be 
interpreted (Dussart et al., 2006) . 
 Interpretation of the examination 
results, negative results: if there is only one 
color line on the control line "C" in the 
reading area of the results on the diagnostic 
kit, this indicates that the negative Non 
Structural Antigen-1 examination results are 
positive: if there are two color lines on the 
"T" test line and the "C" dick line in the 
reading area of the results on the diagnostic 
kit, this indicates that the results of the Non 
Structural Antigen examination are positive, 
invalid results: if in the reading area the 
results of the "C" control mark are not 
visible line, the result is considered invalid. 
This can be caused because the work is not 
in accordance with the instructions on work 
procedures or can be caused by the quality 
of the kit that deteriorates for example 
because the diagnostic kit has been 
expired. Recommended retesting 
specimens (Department of Parasitology FK 
UI, 2008). 
 
Data Management and Analysis 
 The results of the examination data 
obtained are processed by tabulation and 
displayed in table form. The diagnostic test 
results are included in the 2x2 table. The 
2x2 table is then calculated to find 
sensitivity, specificity, positive predictive 
value, negative predictive value, and 
accuracy then Cohen's Kappa statistical 
test is used to determine the degree of 
conformity between the dengue Non 
Structural-1 antigen diagnostic kit currently 
being developed with the commercial 
dengue Non-Structural antigen kit used in 
hospitals, while to see the relationship 
between the examination of dengue Non-
Structural-1 antigen and the results of 
dengue IgGIgM examination 
immunochromatography method used the 
chi-square statistical test and to assess the 
results of Non-Structural-1 antigen 
examination dengue with leukocyte values, 
erythrocytes, hematocrit, hemoglobin and 
platelet values are used Independent t-test 
statistics. Calculation of analysis is done 
using a computer using SPSS 22 software 
for Windows. 
 
RESEARCH RESULT 
 Subject characteristics in this study 
consisted of gender, age, and duration of 
fever (days). In table 1 shows that of 103 
subjects in this study, the number of male 
patients was 62 people (60.2%) and women 
as many as 41 people (39.8%). For the age 
classification in this study,most patients 
were patients aged 21-30 years as many as 
30 people (29.1%) and the least patients 
with age <1 year, only 1 person (1.0%). 
While for the duration of fever (days) of 103 
patients suspected of dengue in this study, 
the highest duration of fever was fever on 
the third day as many as 37 people (35.9%) 
and the least amount was fever on the 7th 
day which was only as much as 2 people 
(1.9%). 
 Table 2 shows that of the 103 
serum samples of patients with suspected 
DHF in this study, the results of the 
examination were obtained using the 
diagnostic kit of the Non Struktrural-1 
dengue antigen which is currently being 
developed with 56 positive samples and 47 
negative samples. while the examination 
using a Non Struktrural-1 commercial 
antigen-1 diagnostic kit used in the hospital 
obtained positive results of 51 samples and 
52 negative results. To determine the 
suitability between the results of the dengue 
NonStructural-1 antigen diagnostic kit 
examination which is currently being 
developed with a commercial dengue 
NonStructural-1 antigen kit used in the 
hospital, the Cohen’s Kappa test was 
conducted. 
The Kappa coefficient value (K) 
obtained from the comparison between the 
dengue Non-Structural-1 antigen diagnostic 
kit currently being developed with the 
commercial dengue Non-Structural-1 
antigen kit used in the hospital is used to 
determine the reliability of the diagnostic 
test. The Cohen's Kappa test results 
obtained a value of p=0,000 (<0.05) 
indicating that there was a significant match 
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between the NS1 kits being developed and 
the commercial NS1 kit used in the hospital 
and having a very good degree of suitability 
because of the value of Cohen's Kappa 
obtained in this study that is equal to 
K=0.903 (> 0.75). 
In this study the determination of the 
level of sensitivity, specificity, positive 
predictive value, negative predictive value 
and accuracy to prove the ability of dengue 
NonStructural-1 antigen diagnostic kits 
currently being developed in detecting 
dengue virus infection compared to 
commercial NonStructural-1 dengue 
antigen kits used in hospitals. Of the 103 
samples in this study, obtained 51 pure 
positive samples (a), 5 false-positive 
samples (b), there were no false-negative 
samples (c) and 47 pure negative samples 
(d). From these results it can be calculated 
the sensitivity of the dengue NonStructural-
1 antigen diagnostic kit that is currently 
being developed which is 100%, specificity 
is 90.4%, positive predictive value is 91.1%, 
negative predictive value is 100%, and 
accuracy value of 95, 1%. 
 
DISCUSSION 
This study involved 103 patients with 
suspected DHF who performed a Non 
Structural-1 dengue antigen 
immunochromatographic method and were 
willing to participate in the study by giving 
informed consent. This amount exceeds the 
minimum sample required in the study. The 
collection and examination of research 
samples were carried out at the Clinical 
Pathology Laboratory of UH Makassar 
Hospital in South Sulawesi Province. 
Based on the characteristics of the 
research subjects, the respondents' gender 
in this study from 103 respondents had 
more male respondents, namely 62 people 
(60.2%) and women as many as 41 people 
(39.8%). This is in line with the research 
conducted by Yondri in 2014 in 69 out of 69 
respondents, the sex of the most dengue 
sufferers, namely 39 men (56.5%), then 30 
women (43.5%) (Yondri, 2013). Then 
another study conducted by Megariani et al 
in 2014 in Padang from 50 respondents 
found that there were more men than 
women, namely 27 (54%) men and 23 
(46%) women (Megariani et al., 2014). The 
same results were obtained by Libraty et al 
in 2002 who obtained more male sufferers 
than women with a ratio of 2: 1 (Libraty et 
al., 2002). Rothman et al. In 2007 stated 
that the low percentage of women with DHF 
compared to men was due to the female 
immune system being better than men. In 
women, more anti-inflammatory production 
is more so that women infected with DHF 
provide less clear clinical complaints and 
rarely experience hospitalization (Megariani 
et al., 2014). Soedarmo et al. In 2009 
stated that XX chromosomes in girls have a 
role in managing immunoglobulin 
production quantitatively (Soedarmo, 2009). 
In contrast to the molecular research 
conducted by Kalayanarooj et al in 2005 in 
Timor Leste, there were more girls 
suspected of having dengue virus infection 
(Kalayanarooj et al., 2005). However, the 
Halstead et al 2004 study proved that there 
was no difference between the infection 
response of girls and boys (Megariani et al., 
2014). 
This is in line with the statement in 
the book "Dengue Fever in Children" by 
Soedarmo in 2009 stated that in Indonesia 
and the Philippines, there is no difference 
between girls and boys who suffer from 
dengue fever (Soedarmo, 2009). Another 
study conducted by NurKhakimatulFaizah 
in 2016 in Jakarta out of 91 respondents 
obtained the number of male dengue 
patients as many as 47 people (51.6%) and 
women as many as 44 (48.4%) people, 
from the results of these studies it appears 
that there is no significant difference 
between male and female DHF patients 
(Nur, 2016). This is also in accordance with 
data from the Ministry of Health of 
Indonesia in 2010 in "Window Epidemiology 
Bulletin, Main Topic: Dengue Hemorrhagic 
Fever" stated that the distribution of dengue 
cases by sex, the percentage of male and 
female sufferers is almost the same. The 
number of sufferers of the male sex is 
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10,463 people (53.78%) and women are 
8,991 people (46.23%). This illustrates that 
the risk of dengue for men and women is 
almost the same, not dependent on gender 
(Epidemiological Data & Surveillance 
Center of the Indonesian Ministry of Health, 
2010). 
Furthermore, the characteristics of 
the research subject are based on age. Age 
is one of the characteristics that can affect 
the condition of a health problem or disease 
because age is very influential on the level 
of exposure, the magnitude of the risk, and 
certain resistance properties. Age is one of 
the important variables because many 
diseases are found with various frequencies 
related to age, some infectious diseases, 
for example, show that a young age has a 
higher risk than adult age (Rosa & M.Sabir, 
2011). 
In this study obtained from 103 
respondents with the youngest age 8 
months (<1 year) and the oldest 60 years, 
the most age is respondents 21-30 years as 
many as 30 people (29.1%), then 
respondents with ages 1-10 years as many 
as 28 people (27.2%) and respondents 
aged 11-20 years as many as 24 people 
(23.3%), respondents with age 31-40 years 
as many as 12 people (11.7%), 
respondents with ages 41-50 years and 
ages 51-60 years have the same value is 
as many as 4 people (3.9%) while the 
respondents with age <1 year at least are 
only as many as 1 person (1.0%). The 
results of this study are in line with the 
research of Rosa DwiWahyuni et al in 2011 
in Makassar showing that the percentage of 
DHF cases according to the highest age 
group was in the 19-49 years age group, 
which were 89 people (43.4%) and followed 
by the 6-14 year age group of 48 people 
(23.4%), while the lowest age group in the 
0-1 year group is as many as 5 people 
(2.4%). Other research that has the same 
results was carried out by Rosmila in Ex. 
TamamaungKec. Panakukang that dengue 
disease is more common in adults, out of 
27 people with dengue there are 26 people 
(30.2%) who are classified as adults and 1 
person (8.3%) who are classified as 
toddlers and children (Rosa & M.Sabir, 
2011) However, the results of this study are 
not in line with the research conducted by 
Yondri in 2014 where the youngest 
respondents were 4 months and the oldest 
61 years, the most aged between 11-20 
years as many as 22 people (31.9%), then 
respondents with ages 2-10 year as many 
as 17 people (24.6%), respondents with 
age 21-30 years and ages> 41 years have 
the same value as many as 8 people 
(11.6%), while respondents with age ≤ 1 
year and 31-40 years with the least amount 
and has the same value as many as 7 
people (10.1%) (Yondri, 2013).  
Furthermore, the characteristics of 
the research subject were based on the 
duration of fever, from 103 respondents of 
patients suspected of DHF in this study, 
based on the duration of the patient's fever 
when admitted to the shortest hospital was 
fever on the 2nd day and the longest was 
the 7th day fever with the most fever Day 3 
fever was 37 people (35.9%), then day 4 
fever was 25 people (24.4%), then day 5 
fever as many as 17 people (16.5%) and 
2nd day fever as many as 16 people ( 
15.5%), 6th day fever as many as 6 people 
(5.8%) and 7th day fever with the lowest 
number, only 2 people (1.9%). This is in line 
with the research conducted by Cindy et al. 
In 2015 in Manado, with 37 of the highest 
number of patients based on the duration of 
the patient's fever when admitted to 
hospital, 21 people (56.8%), later in the 
day. 4 as many as 9 people (24.3%), and 
the fifth day as many as 7 people (18.9%) 
(Cindy et al., 2015). This result is in 
accordance with the theory that the peak 
increase in the level of dengue Non-
Structural-1 antigen increased with the 
highest level on the third day of fever and 
the level will decrease after the fifth day 
(Mitayani, 2011). The results were not 
much different from the ones obtained by 
Megariani et al. In 2014 in Padang from 50 
respondents based on the duration of the 
patient's fever when entering the hospital 
with the highest results, on the third day as 
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many as 28 people (56%), then the second 
day as many as 21 people (42%), and 1st 
day as many as 1 person (2%). In the 2014 
study of Megariani et al. The percentage of 
positive NS1 was greater on day 3 of fever 
compared to day 2, Dussart et al. In 2008 
studied 299 dengue fever patients in 
France, NS1 sensitivity was found on days 
of 0-4 days of fever at 87.6% and 43.5% in 
5-10 day fever. Datta et al in India in 2010, 
comparing NS1 in the acute and 
convalescent phases, found 71.42% 
positive NS1 in the acute phase, whereas in 
the NS1 convalescent-phase there was 
only 6.38% positive. The sensitivity of NS1 
is high in the early phase of fever because 
NS1 protein circulates in high 
concentrations in the patient's blood during 
the initial acute phase, both in primary and 
secondary infections. High levels of NS1 
until the 5th day of fever are associated 
with the time of occurrence of viremia 
because it is a period of viral replication and 
the absence of antibodies to the virus. The 
levels of viremia and NS1 levels also 
depend on the intrinsic characteristics of 
the infecting virus strains and the immunity 
status of the patients themselves 
(Megariani et al., 2014). 
In this study the researchers tested 
the level of suitability of the test results 
between the Non Struktrural-1 dengue 
antigen kit which is currently being 
developed with the Non Structural-1 
commercial antigen kit used in hospitals 
obtained results from 103 serum samples of 
patients with suspected DHF in this study, 
obtained the results of the examination are 
the results of testing using a dengue Non 
Struktrural-1 antigen diagnostic kit which is 
currently being developed obtained 56 
positive samples and 47 samples are 
negative, while the examination uses a 
commercial Non-Structural-1 dengue 
antigen diagnostic kit used at home pain 
obtained positive results of 51 samples and 
negative results of 52 samples. To 
determine the suitability between the results 
of the dengue Non-Structural-1 antigen 
diagnostic kit examination which is currently 
being developed with a commercial dengue 
Non-Structural-1 antigen kit used in the 
hospital, the Cohen’s Kappa test was 
conducted. The Cohen's Kappa test results 
obtained a value of p = 0,000 (<0.05) which 
indicates that there is a significant suitability 
of test results between NS1 kits being 
developed with commercial NS1 kits used 
in hospitals and having a very good degree 
of suitability because of the value of 
Cohen's Kappa obtained in this study that is 
equal to K = 0.903 (> 0.75). 
In this study the determination of the 
sensitivity level, specificity, positive 
predictive value, negative predictive value 
and accuracy to prove the ability of the 
dengue Non-Structural-1 antigen diagnostic 
kit currently being developed in detecting 
dengue virus infection compared to Non-
Structural-1 dengue antigen kits 
commercial used in hospitals. Of the 103 
samples in this study, obtained 51 pure 
positive samples (a), 5 false-positive 
samples (b), there were no false-negative 
samples (c) and 47 pure negative samples 
(d). From these results it can be calculated 
the sensitivity of the dengue Non-Structural-
1 antigen diagnostic kit that is currently 
being developed which is 100%, specificity 
90.4%, positive predictive value 91.1%, 
negative predictive value 100%, and 
accuracy value of 95, 1%. In this study 
there were different examination results 
between the results of the NS1 kit test that 
was being developed and the commercial 
NS1 kit used in the hospital, which was 5 
samples. Where on the examination using a 
nonStructural-1 commercial antigen kit 
used in the hospital negative results were 
obtained while the examination using a 
dengue Non-Struktrural-1 antigen 
diagnostic kit which is currently being 
developed is obtained by positive 
examination results. The five samples that 
gave different results (false positives) were 
examined using the PCR method as the 
gold standard to determine the detection 
results of dengue Non-Structural 1 antigen, 
in theory Virus isolation and PCR was still 
the gold standard for detecting dengue 
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virus. In this study, the researchers chose 
to determine the results of five samples that 
gave different results. Further testing was 
done using PCR instead of virus isolation 
because there were limitations to the 
examination, especially the time and 
processing techniques. The results of the 
examination using the PCR method as the 
gold standard gave negative results to 
these 5 samples, this is probably due to the 
storage process of the sample which is not 
in accordance with the standard because 5 
samples that have different incubation at -
20 ° C for 6 months RNA can be 
ascertained from dengue virus is likely to 
have been damaged, this is in line with the 
research conducted by EnnyNugraheni et 
al. 2016 in Bengkulu on "Molecular 
Diagnosis of Dengue Virus" in his study 
stated that for storage management of 
samples the PCR method was examined in 
detecting dengue virus RNA, a virus that 
will directly checked stored at -4 ° C or -8 ° 
C for inspection less than 24 hours, but if 
the inspection is carried out more than 24 
hours the sample storage must be stored at 
-70°C and maintained so that no 
liquefaction occurs to prevent damage 
Dengue virus RNA due to dengue virus 
including virus which is labile to 
temperature and other chemical factors 
(Nugraheni & Sulistyowati, 2016). Five 
samples that gave different results had also 
been carried out with dengue IgM and IgG 
examination and gave results from these 5 
samples. 4 samples gave positive dengue 
IgM immunochromatography method while 
1 sample obtained negative IgM dengue 
immunochromatography method, whereas 
for dengue IgG immunochromatography 
method of 5 Different samples examined by 
4 samples obtained negative results of 
dengue IgG immunochromatography 
method and 1 dengue positive IgG 
immunochromatography method, IgG and 
IgM degue immunochromatography method 
was performed using fresh serum (less than 
24 hours) before the serum sample of 
patients suspected of dengue was frozen at 
temperature of -20 ° C. 
The results of this study are in line 
with the research conducted by Megariani 
et al. In Padang in his study to determine 
sensitivity, specificity, positive and negative 
predictive values and determine the 
accuracy level to prove the ability of NS1 to 
diagnose dengue virus infection compared 
to PCR as the gold standard. In his 
research obtained 50 samples suspected of 
having dengue virus infection. 24 positive 
samples correctly suffered DHF (a), 1 false-
positive sample (b), 2 false-negative 
samples (c), and 23 true negative samples 
(d). then the results of NS1 sensitivity were 
92.3%, specificity 95.8%, positive predictive 
value 96%, negative predictive value 92% 
and NS1 accuracy for diagnosis of dengue 
virus infection by 94%. From these results 
there were 24 samples that gave positive 
results both with PCR and rapid test NS1 
while using PCR 26 positive samples were 
obtained while using the NS1 rapid test only 
25 samples were positive. From the results 
of the test carried out the Kappa test and 
obtained a value of 0.88 which shows the 
suitability of the results between PCR and 
rapid test NS1 for the diagnosis of dengue 
virus infection with a value of p = 0,000 
(<0.05) (Megariani et al, 2014). However, 
the results of this study are different from 
the results obtained in a study conducted 
by Paisal et al. 2016 in Jakarta to examine 
the suitability of detection of RT PCR, NS1 
RDT, and IgM RDT results in patients with 
dengue disease. The results obtained were 
the suitability of the test results between RT 
PCR examination and NS1 RDT and RT 
PCR examination with IgM RDT in 
diagnosing dengue disease, Cohen’s 
Kappa test was performed. The results of 
Cohen’s Kappa test obtained for RT PCR 
examination with RDT NS1 found that the 
suitability was only a moderate level of 
value (K = 0.404, p = 0,000). Whereas for 
RT PCR examination with IgM RDT only 
had a very small match (K = 0.139, p = 
0.046). It can be concluded that the 
suitability of NS1 RDT detection against RT 
PCR examination is only a moderate level 
and the suitability of RT PCR detection 
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compared to IgM RDT only has very little 
suitability (Paisal et al., 2016). 
 
CONCLUSIONS AND 
RECOMMENDATIONS 
There is a conformity of the results of 
a significant examination between the Non-
Structural-1 antigen kit which is currently 
being developed with the commercial Non-
Structural-1 antigen kit used in hospitals 
using immunochromatography methods 
and has a very good level of suitability, and 
the level of sensitivity of the kit is obtained 
Dengue Non-structural antigen diagnostic 
currently being developed that is compared 
with commercial NS1 kits is 100%, 
specificity is 90.4%, positive predictive 
value is 91.1%, negative predictive value is 
100% and accuracy value is 95.1%. 
Based on these results it can be 
suggested that further research is needed 
in the form of a comparative test between 
dengue Non Structural-1 antigen diagnostic 
kits currently being developed with a gold 
standard examination to detect the 
presence of dengue viruses such as 
dengue virus isolation culture or PCR 
examination of all patient serum samples 
suspects of DHF, in order to be able to 
assess the determination of the level of 
sensitivity, specificity, positive predictive 
value, negative predictive value and 
accuracy compared to the gold standard 
examination to detect the presence of 
dengue virus to prove the ability of the 
Dengue Non-Structural-1 antigen diagnostic 
kit currently being developed in detecting 
presence of dengue virus infection. 
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ATTACHMENT 
Table 1. Characteristics of Research Subjects 
 
Characteristics of Research Subjects Total 
(n = 103) 
Percentage 
(100 %) 
Gender 
 
Male 
Female 
62 
41 
60,2 
39,8 
Age Classification 
(Year) 
 
 
<1 
1 - 10 
11 - 20 
21 - 30 
31 - 40 
41 - 50 
51 - 60 
1 
28 
24 
30 
12 
4 
4 
 
1,0 
27,2 
23,3 
29,1 
11,7 
3,9 
3,9 
 
Old Fever (Day) 
 
≤ 2 
3 
4 
5 
6 
≥ 7 
16 
37 
25 
17 
6 
2 
15,5 
35,9 
24,3 
16,5 
5,8 
1,9 
 
 
Tabel 2. Conformance Test Results Between NS1 Kits that are Being Developed with   
                 Commercial NS1 Kits 
 
Developed NS 1 
Commercial NS 1 
Total Value p* 
Cohen’s 
Kappa 
Positive Negative 
Positive 51 5 56 
0,000 0,903 Negative 0 47 47 
Total 51 52 103 
*Uji Cohen’s Kappa 
- Sensitivity  = 100 % 
- Specificity  = 90,4 % 
- Value is positive  = 91,1% 
- Value is negative  = 100% 
- Accuracy   = 95,1% 
